metricas
covid
Buscar en
Vacunas
Toda la web
Inicio Vacunas Adverse events following COVID-19 vaccination among pregnant women attending pri...
Journal Information

Statistics

Follow this link to access the full text of the article

Original
Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance study
Narayana Goruntlaa,
Corresponding author
drgoruntla@kiu.ac.ug

Corresponding author.
, Basappa Karisettyb, Nandini Nandinib, Bharadwaj Bhupasamudramb, Himaja Reddy Gangireddyb, Kasturi Vishwanathasetty Veerabhadrappac, Joseph Obiezu Chukwujekwu Ezeonwumelua, Vishnuvandana Bandarud
a Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy, Kampala International University, Western Campus, Uganda
b Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research (RIPER) – Autonomous, Anantapur, Andhra Pradesh, India
c Department of Pharmacognosy and Pharmaceutical Chemistry, School of Pharmacy, Kampala International University, Western Campus, Uganda
d Department of Pharmaceutical Analysis, Balaji College of Pharmacy, Anantapur, Andhra Pradesh, India
Read
551
Times
was read the article
157
Total PDF
394
Total HTML
Share statistics
Article information
ISSN: 15769887
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 13 17 30
2024 October 25 12 37
2024 September 25 11 36
2024 August 25 11 36
2024 July 27 14 41
2024 June 25 15 40
2024 May 25 15 40
2024 April 20 12 32
2024 March 41 18 59
2024 February 41 8 49
2024 January 15 0 15
2023 December 17 7 24
2023 November 27 10 37
2023 October 29 0 29
2023 September 10 0 10
2023 August 13 0 13
2023 July 13 2 15
2023 June 3 5 8
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos